R&D Breaking into the global pharmaceutical market In 2022, pharma is truly a global industry, and innovation can come from anywhere.
News Digital health accelerator Pulse launches in Boston Selected start-ups will receive part of a $250,000 pot.
News Akebia joins GSK in US market for oral CKD anaemia drugs The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS
Digital Sponsored Innovation as Strategy: Enabling life sciences of the future Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.